OQS
OMGA

Occudo Quantitative Strategies’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Occudo Quantitative Strategies’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,534
Closed -$63K – 1448
2022
Q3 		$63K Sell
11,534
-6,789
-37% -$34.4K ﹤0.01% 1075
2022
Q2 		$70K Buy
+18,323
New +$68.2K 0.01% 1045

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Occudo Quantitative Strategies's OMGA Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q4 2022, closing a stake of 11,534 shares — an estimated $63K sold.

Occudo Quantitative Strategies first reported a position in OMGA in Q2 2022 and held it in 2 quarters. The position peaked at $70K in Q2 2022. 49 funds tracked by Wall St. Rank hold OMGA as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 11,534 Omega Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $63K.
  • Occudo Quantitative Strategies first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Omega Therapeutics, Inc. Common Stock position peaked at $70K in Q2 2022.
  • 49 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.